The role of epidural phenol in cancer patients at the end of life

Abstract

Get full access to this article

View all access options for this article.

References

1 Weiss SC Emanuel LL Fairclough DL Emanuel EJ . Understanding the experience of pain in terminally ill patients. Lancet 2001; 357: 1311–1315.

2 Mercadante S . Problems of long term spinal opioid treatment in advanced cancer patients. Pain 1999; 79: 1–13.

3 Meuser T Pietruck C Radbruch L Stute P Lehmann KA Grond S . Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain 2001; 93: 247–257.

4 Zech DFG Grond S . Validation of WHO guidelines for cancer pain relief: a 10 year prospective study. Pain 1995; 63: 67–69.

5 Swerdlow M . Role of chemical neurolysis and local anaesthetic infiltration. In: Swerdlow, M, Ventafridda, V, (eds), Cancer pain. Lancaster: MTP press limited; 1987. p. 105–129.

6 Colpitts MR Levy BA Lawrence M . Treatment of cancer-related pain with phenol epidural block. In: Pain abstracts, vol. 1. Seattle: The international association for the study of pain; 1978. p. 147.

7 Salmon JB Finch PM Lovegrove FT Warwick A . Mapping the spread of epidural phenol in cancer pain patients by radionuclide admixture and epidural scintigraphy. Clin J Pain 1992; 8: 18–22.

8 World Health Organisation . Cancer pain relief. Geneva: World Health Organisation; 1986.

9 Baker S Regnard C Crack L Callin S . Evolving spinal analgesia practice in palliative care. Palliat Med 2004; 18: 507–515.

10.

10 Deer T Krames ES Hasselbruch SJ Burton A Caraway D Dupen S . Polyanalgesic consensus conference: recommendations for the management of pain by intrathecal (intraspinal) drug delivery; report of an interdisciplinary expert panel. Neuromodulation 2007; 10: 300–328.